Cargando…

Yishen Xiezhuo formula ameliorates the development of cisplatin-induced acute kidney injury by attenuating renal tubular epithelial cell senescence

BACKGROUND: Although cisplatin (DDP) is an important clinical anti-tumor drug, its use is limited by its nephrotoxicity. How to avoid the renal injury incurred by platinum drugs and improve the clinical efficiency of platinum drugs use has become an urgent clinical problem. Previous studies have ver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qiaoying, Qi, Jieying, Luo, Qin, Wu, Mengni, Zhang, Lili, Qin, Linsen, Nie, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843381/ https://www.ncbi.nlm.nih.gov/pubmed/36660714 http://dx.doi.org/10.21037/atm-22-5415

Ejemplares similares

Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
por: Wang, Weimin, et al.
Publicado: (2023)

Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway
por: Li, Min-yan, et al.
Publicado: (2022)

Effects of Tiaopi Xiezhuo decoction on constipation and gut dysbiosis in patients with peritoneal dialysis
por: Peng, Yu, et al.
Publicado: (2023)

Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model
por: Li, Jiansheng, et al.
Publicado: (2014)

Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments
por: Fan, Lifei, et al.
Publicado: (2023)

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro
por: Jia, Qi, et al.
Publicado: (2022)

Repair mechanism of Yishen Tongluo formula on mouse sperm DNA fragmentation caused by polystyrene microplastics
por: Zhang, Chenming, et al.
Publicado: (2023)

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via Regulating Mitochondrial Dysfunction Induced by Oxidative Stress in Unilateral Ureteral Obstruction Rats
por: Jia, Qi, et al.
Publicado: (2021)

Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway
por: Mo, Yenan, et al.
Publicado: (2021)

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
por: Zhang, Difei, et al.
Publicado: (2021)

Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier
por: Zhao, Tingting, et al.
Publicado: (2022)

Bushen-Yizhi formula ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in scopolamine-induced senescence in mice
por: HOU, XUE-QIN, et al.
Publicado: (2014)

A network pharmacology approach to determine the underlying mechanisms of action of Yishen Tongluo formula for the treatment of oligoasthenozoospermia
por: Chen, Yangdi, et al.
Publicado: (2021)

Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
por: Mao, Wei, et al.
Publicado: (2021)

Exogenous spermidine ameliorates tubular necrosis during cisplatin nephrotoxicity
por: Yoon, Sang Pil, et al.
Publicado: (2018)

Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling
por: Xu, Kexin, et al.
Publicado: (2023)

Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease
por: Li, Jiansheng, et al.
Publicado: (2015)

Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity
por: Sun, Xian, et al.
Publicado: (2022)

Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS
por: Wu, Jinyan, et al.
Publicado: (2022)

Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy
por: Fang, Jingai, et al.
Publicado: (2022)

In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells
por: Kurosaki, Yoshifumi, et al.
Publicado: (2022)

Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity
por: Li, Siyao, et al.
Publicado: (2023)

Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS
por: Yang, Liping, et al.
Publicado: (2015)

The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast
por: Li, Yangyang, et al.
Publicado: (2020)

Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway
por: Zhang, Ziyuan, et al.
Publicado: (2022)

Tubular aryl hydratocarbon receptor upregulates EZH2 to promote cellular senescence in cisplatin-induced acute kidney injury
por: Wen, Li, et al.
Publicado: (2023)

Corrigendum to “The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast”
por: Li, Yangyang, et al.
Publicado: (2021)

Isoliquiritin Ameliorates Cisplatin-Induced Renal Proximal Tubular Cell Injury by Antagonizing Apoptosis, Oxidative Stress and Inflammation
por: Pei, Zhiyin, et al.
Publicado: (2022)

Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule)
por: Fang, Jingai, et al.
Publicado: (2013)

Cellular senescence of renal tubular epithelial cells in renal fibrosis
por: Zhang, Jun-Qing, et al.
Publicado: (2023)

Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage
por: Yoshioka, Toshihiko, et al.
Publicado: (2023)

Nicotinamide Mononucleotide Attenuates Renal Interstitial Fibrosis After AKI by Suppressing Tubular DNA Damage and Senescence
por: Jia, Yan, et al.
Publicado: (2021)

Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease
por: Zhao, Peng, et al.
Publicado: (2018)

Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
por: Hu, Yaling, et al.
Publicado: (2022)

Berberine alleviates cisplatin-induced acute kidney injury by regulating mitophagy via PINK 1/Parkin pathway
por: Qi, Jieying, et al.
Publicado: (2020)

Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats
por: Tian, Yange, et al.
Publicado: (2015)

Xiaoyu Xiezhuo Drink Protects against Ischemia-Reperfusion Acute Kidney Injury in Aged Mice through Inhibiting the TGF-β1/Smad3 and HIF1 Signaling Pathways
por: Ye, Qingqing, et al.
Publicado: (2021)

Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation
por: Sun, Xian, et al.
Publicado: (2022)

Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-κB Signaling
por: Jin, Fanli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rmi1nd2ec52b6g6fpmfduv31ki